CLINICAL_TRIALS
trial_result
· 2017-12-26
Clinical Trial Update: Efficacy and Safety Study of QVA149 in COPD Patients [Phase 3]
Summary
Phase 3 trial update on the efficacy and safety of QVA149 in COPD patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-12-26